Novartis | Despesas De Vendas E Administração



Selling And Administration Expenses Alterar Data
AbbVie USD 3.29B 562M 2025-03
Amgen USD 1.69B 191M 2025-03
AstraZeneca USD 3.59B 1.96B 2025-03
Bausch Health Companies USD 867M 47M 2025-03
Biogen USD 572.5M 104.8M 2025-03
Bristol-Myers Squibb USD 1.58B 521M 2025-03
Canopy Growth CAD 40.62M 308K 2024-12
Corcept Therapeutics USD 90.66M 7.29M 2025-03
Drreddys Laboratories INR 21.59B 436M 2024-12
Eli Lilly USD 2.36B 62.3M 2025-03
Gilead Sciences USD 1.26B 603M 2025-03
GlaxoSmithKline GBP 2.06B 603M 2025-03
Glaxosmithkline GBP 2.7B 632M 2024-12
Indivior 132M 179M 2025-03
J&J USD 5.11B 1.34B 2025-03
Merck USD 2.53B 319M 2025-03
Novartis USD 3.5B 368M 2024-12
Novartis USD 3.5B 368M 2024-12
Pacira USD 86.78M 7.16M 2025-03
Perrigo USD 281.2M 46.4M 2025-03
Pfizer USD 3.01B 1.27B 2025-03
Prestige Brands USD 64.05M 73K 2025-03
Roche Holding CHF 3.61B 381M 2024-12
Sanofi EUR 2.22B 980M 2025-03
Sanofi EUR 1.24B 1.44B 2024-12
Supernus Pharmaceuticals USD 79.41M 9.66M 2024-12
Zoetis USD 563M 62M 2025-03



Novartis Despesas De Vendas E Administração - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Jul 2025.